Towards an assay of global immune competence | Holden Maecker, PhD

Evan Maecker, PhD, describes the need for the development of a global assay of immunocompetence. The vast diversity of the immune system requires a high-dimensional analysis to profile the normal state of the immune system and understand underlying changes in diseases like cancer and HIV. This presentation describes mass cytometry as a research platform for the monitoring of patients on cancer immunotherapy and patients with HIV infection.